BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10773596)

  • 1. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
    Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
    Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C; Balogh A; Balázs G; Lukács G
    Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects.
    Zerwekh JE; Ruml LA; Gottschalk F; Pak CY
    J Bone Miner Res; 1998 Oct; 13(10):1594-601. PubMed ID: 9783548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
    Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
    Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of changes in bone density after operation for primary hyperparathyroidism.
    Bergenfelz A; Lindergård B; Ahrén B
    Ann Chir Gynaecol; 1993; 82(4):245-9. PubMed ID: 8122872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperparathyroidism: lessons from bone histomorphometry.
    Eriksen EF
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism.
    Yajima A; Inaba M; Ogawa Y; Tominaga Y; Tanizawa T; Inou T; Otsubo O
    Nephrol Dial Transplant; 2007 Jun; 22(6):1645-57. PubMed ID: 17307749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism.
    Osterode W; Winker R; Bieglmayer C; Vierhapper H
    Bone; 2004 Oct; 35(4):942-7. PubMed ID: 15454101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.
    Ste-Marie LG; Sod E; Johnson T; Chines A
    Calcif Tissue Int; 2004 Dec; 75(6):469-76. PubMed ID: 15478000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy.
    Christiansen P; Steiniche T; Brixen K; Hessov I; Melsen F; Heickendorff L; Mosekilde L
    Bone; 1999 Aug; 25(2):237-44. PubMed ID: 10456391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
    Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
    J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histomorphometric study of cortical bone of the iliac crest in patients treated with glucocorticoids.
    Vedi S; Elkin SL; Compston JE
    Calcif Tissue Int; 2005 Aug; 77(2):79-83. PubMed ID: 16086108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabecular and cortical bone in the radii of women with parathyroid adenomata: a greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy.
    Hesp R; Tellez M; Davidson L; Elton A; Reeve J
    Bone Miner; 1987 Jul; 2(4):301-10. PubMed ID: 3505765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism and the skeleton.
    Mosekilde L
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
    Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.